Skip to main content
PMC home page
American Journal of Public Health and the Nation's Health logoLink to American Journal of Public Health and the Nation's Health
. 1957 Apr;47(4 Pt 1):421–431. doi: 10.2105/ajph.47.4_pt_1.421

Observations on Natural Poliovirus Infections in Immunized Children

Henry M Gelfand, John P Fox, Dorothy R LeBlanc
PMCID: PMC1551137  PMID: 13411317

Full text

PDF
422

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BODIAN D. Emerging concept of poliomyelitis infection. Science. 1955 Jul 15;122(3159):105–108. doi: 10.1126/science.122.3159.105. [DOI] [PubMed] [Google Scholar]
  2. BODIAN D. Experimental studies on passive immunization against poliomyelitis. III. Passive-active immunization and pathogenesis after virus feeding in chimpanzees. Am J Hyg. 1953 Jul;58(1):81–100. doi: 10.1093/oxfordjournals.aje.a119594. [DOI] [PubMed] [Google Scholar]
  3. BROWN G. C., RABSON A. S., SCHIEBLE J. H. The effect of gamma globulin of sub-clinical infection in familial associates of poliomyelitis cases. I. Quantitative estimation of fecal cirus. J Immunol. 1954 Jul;73(1):54–61. [PubMed] [Google Scholar]
  4. FLACK A., HUMMELER K., HUNT A. D., Jr, JERVIS G. A., KOPROWSKI H., NORTON T. W., STOKES J., Jr Immunization of infants with living attenuated poliomyelitis virus; laboratory investigations of alimentary infection and antibody response in infants under six months of age with congenitally acquired antibodies. J Am Med Assoc. 1956 Dec 1;162(14):1281–1288. [PubMed] [Google Scholar]
  5. FOX J. P., GELFAND H. M., LEBLANC D. R., CONWELL D. P. A continuing study of the acquisition of natural immunity to poliomyelitis in representative Louisiana households. Am J Public Health Nations Health. 1956 Mar;46(3):283–294. doi: 10.2105/ajph.46.3.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. HAMMON W. M., CORIELL L. L., WEHRLE P. F., STOKES J., Jr Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. IV. Final report of results based on clinical diagnoses. J Am Med Assoc. 1953 Apr 11;151(15):1272–1285. [PubMed] [Google Scholar]
  7. HORSTMANN D. M., MELNICK J. L. Poliomyelitis in chimpanzees; studies in homologous and heterologous immunity following inapparent infection. J Exp Med. 1950 Jun 1;91(6):573–597. doi: 10.1084/jem.91.6.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. HOWE H. A., BODIAN D., MORGAN I. M. Subclinical poliomyelitis in the chimpanzee and its relation to alimentary reinfection. Am J Hyg. 1950 Jan;51(1):85-108, tab. doi: 10.1093/oxfordjournals.aje.a119379. [DOI] [PubMed] [Google Scholar]
  9. HOWE H. A. Studies of active immunogenesis in poliomyelitis. I. Persistence and recall by homotypic or heterotypic superinfection of neutralizing antibody originally induced in chimpanzees by vaccination or infection. Am J Hyg. 1954 Nov;60(3):371–371. [PubMed] [Google Scholar]
  10. KOPROWSKI H., NORTON T. W., JERVIS G. A., NELSON T. L., CHADWICK D. L., NELSEN D. J., MEYER K. F. Clinical investigations on attenuated strains of poliomyelitis virus; use as a method of immunization of children with living virus. J Am Med Assoc. 1956 Mar 17;160(11):954–966. doi: 10.1001/jama.1956.02960460032008. [DOI] [PubMed] [Google Scholar]
  11. LANGMUIR A. D., NATHANSON N., HALL W. J. Surveillance of poliomyelitis in the United States in 1955. Am J Public Health Nations Health. 1956 Jan;46(1):75–88. doi: 10.2105/ajph.46.1.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. MELNICK J. L. Antigenic crossings with in poliovirus types. Proc Soc Exp Biol Med. 1955 May;89(1):131–133. [PubMed] [Google Scholar]
  13. SABIN A. B. Immunity in poliomyelitis, with special reference to vaccination. Monogr Ser World Health Organ. 1955;26:297–334. [PubMed] [Google Scholar]
  14. SABIN A. B. Pathogenesis of poliomyelitis; reappraisal in the light of new data. Science. 1956 Jun 29;123(3209):1151–1157. doi: 10.1126/science.123.3209.1151. [DOI] [PubMed] [Google Scholar]
  15. SABIN A. B. Present status of attenuated live-virus poliomyelitis vaccine. J Am Med Assoc. 1956 Dec 29;162(18):1589–1596. doi: 10.1001/jama.1956.02970350005002. [DOI] [PubMed] [Google Scholar]
  16. SALK J. E., BAZELEY P. L., BENNETT B. L., KRECH U., LEWIS L. J., WARD E. N., YOUNGNER J. S. Studies in human subjects on active immunization against poliomyelitis. II. A practical means for inducing and maintaining antibody formation. Am J Public Health Nations Health. 1954 Aug;44(8):994–1009. doi: 10.2105/ajph.44.8.994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. SALK J. E. Considerations in the preparation and use of poliomyelitis virus vaccine. J Am Med Assoc. 1955 Aug 6;158(14):1239–1248. doi: 10.1001/jama.1955.02960140001001. [DOI] [PubMed] [Google Scholar]
  18. SALK J. E., YOUNGNER J. S., WARD E. N. Use of color change of phenol red as the indicator in titrating poliomyelitis virus or its antibody in a tissue-culture system. Am J Hyg. 1954 Sep;60(2):214–230. doi: 10.1093/oxfordjournals.aje.a119714. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health and the Nations Health are provided here courtesy of American Public Health Association

RESOURCES